Stocks in Focus

SKAI Signs Strategic Agreement with Global Robotics Firm ABB… Up 16% [Featured Stock]

[Edaily Reporter Lee Hye-ra] SK Intelligence (#SKAI) is up more than 16% in early trading.
According to MP Doctor on the 10th, SKAI is trading at 5,010 won as of 9:15 a.m. today, up 16.40% from the previous trading day.
SKAI is a digital twin and synthetic data infrastructure company. The surge in buying interest is believed to be driven by news that the company has signed a strategic cooperation framework agreement with ABB Robotics (hereinafter ABB), a global industrial robotics and automation company.
This agreement was initiated to combine ABB’s robot simulation software, Robot Studio, with SKAI’s ultra-precise synthetic data generation pipeline.
ABB is a global leader in industrial robotics. In collaboration with NVIDIA, ABB is working to build an industrial AI (artificial intelligence) simulation environment by integrating NVIDIA Omniverse into ABB Robotics Studio for the development of next-generation industrial robots.
Through this agreement, SKAI plans to jointly develop and validate physical AI infrastructure with ABB.

Economy

Corporation

IT·Science

Economy

A Semiconductor Fabless Company Founded by SK Hynix’s Youngest-Ever Executive [VC Cradle]

The biggest bottleneck for AI servers is memory. As the KV cache—where large language models (LLMs) store past computations—accumulates, the required memory capacity increases exponentially. This prob…
2026-07-04 09:00:07

Corporation

Genosco, Tax Risk?… “Lecraza Is ‘Royalty Income’; Its Value Remains Unchanged”

Concerns about “tax risks” have been raised in some quarters of the financial investment, pharmaceutical, and biotech markets regarding Genosco, a subsidiary of OSCOTEC Inc.(039200)specializing in new…
2026-07-04 08:31:02

IT·Science

Celltrion Pharm Inc. Builds a Plant, AriBio Secures Investment… K-Bio in ‘Expansion Mode’ [Weekly Bio Roundup]

As July began (June 29–July 3), the pharmaceutical and biotech industries turned their attention to Celltrion Pharm Inc.’s large-scale investment in production facilities and AriBio’s successful fundr…
2026-07-04 09:01:02